96 related articles for article (PubMed ID: 3057093)
1. Alpha 2-plasmin inhibitor and its deficiency states.
Saito H
J Lab Clin Med; 1988 Dec; 112(6):671-8. PubMed ID: 3057093
[No Abstract] [Full Text] [Related]
2. Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
Colucci G; Alberio L; Jahns M; Keller P; Steiner S; Rüsges-Wolter I; Lämmle B
Thromb Haemost; 2009 Dec; 102(6):1285-7. PubMed ID: 19967165
[No Abstract] [Full Text] [Related]
3. The importance of alpha 2-antiplasmin in the defibrination syndrome.
Wolf PL
Arch Intern Med; 1989 Aug; 149(8):1724-5. PubMed ID: 2475077
[No Abstract] [Full Text] [Related]
4. [Clinical significance of alpha 2-plasmin inhibitor analysis in blood coagulation and fibrinolysis tests].
Hayashi T; Suzuki K
Nihon Rinsho; 1989 Dec; 48 Suppl():869-71. PubMed ID: 2516162
[No Abstract] [Full Text] [Related]
5. Inhibitors of the fibrinolytic enzyme system.
Aoki N; Harpel PC
Semin Thromb Hemost; 1984 Jan; 10(1):24-41. PubMed ID: 6199845
[No Abstract] [Full Text] [Related]
6. [Changes in protein C inhibitor in disseminated intravascular coagulation: relationship with heparin cofactor II and alpha 2-plasmin inhibitor].
Kazama Y; Takahashi K; Oguma Y; Sakuragawa N
Rinsho Ketsueki; 1988 Mar; 29(3):344-8. PubMed ID: 3398266
[No Abstract] [Full Text] [Related]
7. Metabolism of fibrinolytic system, especially that of alpha 2 plasmin inhibitor deficient patient.
Sakata Y
Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1506-12. PubMed ID: 7342652
[No Abstract] [Full Text] [Related]
8. Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Williams EC
Arch Intern Med; 1989 Aug; 149(8):1769-72. PubMed ID: 2475079
[TBL] [Abstract][Full Text] [Related]
9. Variation of alpha 2-plasmin inhibitor in patients with gastric cancer.
Kageyama T; Oyabu H; Tsumoto S; Ohshiba S
Bull Osaka Med Sch; 1984 Oct; 30(2):89-95. PubMed ID: 6571385
[No Abstract] [Full Text] [Related]
10. [Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC)].
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Fuse I; Satoh K; Wada K; Shibata A
Rinsho Ketsueki; 1988 Mar; 29(3):336-43. PubMed ID: 3260969
[No Abstract] [Full Text] [Related]
11. Acquired alpha-2 anti-plasmin deficiency secondary to amyloidosis.
Clyne LP; Caldwell AB
Thromb Haemost; 1987 Aug; 58(2):797. PubMed ID: 3672434
[No Abstract] [Full Text] [Related]
12. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
Du XH; Glas-Greenwalt P; Kant KS; Allen CM; Hayes S; Pollak VE
Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
Meyer K; Williams EC
Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
[TBL] [Abstract][Full Text] [Related]
14. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
Carpenter SL; Mathew P
Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
16. Coagulopathy in a patient with nephrotic syndrome.
Ghanny S; Ross C; Chan AK; Chan HH
Am J Hematol; 2010 Sep; 85(9):708-10. PubMed ID: 20669179
[No Abstract] [Full Text] [Related]
17. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC].
Ikematsu S; Kato M; Kuroso K
Rinsho Byori; 1984 Aug; 32(8):862-8. PubMed ID: 6502985
[No Abstract] [Full Text] [Related]
18. Plasma alpha2-plasmin inhibitor levels in patients with leukemia.
Kageyama T; Oyabu H; Dohi T; Matsumoto K; Tsumoto S
Bull Osaka Med Sch; 1983 Jul; 29(1):36-42. PubMed ID: 6589023
[No Abstract] [Full Text] [Related]
19. [Levels of antithrombin III and alpha 2-plasmin inhibitor in bone marrow aspirate].
Tsurumi N; Hayashi H; Ishimaru F; Fujita T; Takai Y; Tsuda T; Kimura I
Rinsho Ketsueki; 1988 Aug; 29(8):1207-13. PubMed ID: 3204671
[No Abstract] [Full Text] [Related]
20. [Molecular basis for hereditary deficiency of alpha 2-plasmin inhibitor].
Aoki N; Miura O
Rinsho Byori; 1990 Jul; Suppl 86():109-15. PubMed ID: 2232232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
